EXS3:F:F-iShares MDAX® UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 223.65

Change

-0.10 (-0.04)%

Market Cap

USD 1.06B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.10 (+0.39%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

N/A

USD 117.80B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.14 (+0.26%)

USD 92.18B
SXR8:F iShares Core S&P 500 UCITS ETF..

+2.58 (+0.49%)

USD 85.13B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.07 (+0.30%)

USD 75.40B
EUNL:F iShares Core MSCI World UCITS ..

-0.08 (-0.08%)

USD 72.04B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 56.70B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 55.70B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.58 (+0.60%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.75 (+0.79%)

USD 51.63B

ETFs Containing EXS3:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.27% 29% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.27% 27% F 39% F
Trailing 12 Months  
Capital Gain 0.79% 27% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.79% 25% F 42% F
Trailing 5 Years  
Capital Gain 4.24% 34% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.24% 34% F 33% F
Average Annual (5 Year Horizon)  
Capital Gain 2.27% 52% F 56% F
Dividend Return 2.27% 50% F 51% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.73% 22% F 59% D-
Risk Adjusted Return 11.48% 44% F 49% F
Market Capitalization 1.06B 74% C 59% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.